Mary Ann Liebert: Using Cardiac-Specific Biomarkers to Predict Cardiovascular Disease Risk Early
November 12, 2019
November 12, 2019
NEW ROCHELLE, New York, Nov. 12 -- Mary Ann Liebert Inc. issued the following news release:
A new review article provides valuable insights into how traditional and emerging cardiac-specific biomarkers and their associated cardiovascular disease (CVD) risk factors may help point to effective preventive interventions in high-risk obese populations starting at an early stage of disease development. The growing problem of childhood obesity makes the identification of CVD biomarkers to . . .
A new review article provides valuable insights into how traditional and emerging cardiac-specific biomarkers and their associated cardiovascular disease (CVD) risk factors may help point to effective preventive interventions in high-risk obese populations starting at an early stage of disease development. The growing problem of childhood obesity makes the identification of CVD biomarkers to . . .